Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche, Reloaded
Investopedia
Wednesday, May 22, 2013 - 9:22am
tags:
Roche, Gilead, Merck, Bristol-Myers Squibb, JNJ
Merck to Buy Back $5 Billion of Its Shares From Goldman
Bloomberg
Wednesday, May 22, 2013 - 9:12am
tags:
Merck, stock buybacks
Pfizer to spin off Zoetis stake to shareholders
Yahoo/Reuters
Wednesday, May 22, 2013 - 9:08am
tags:
Zoetis, Pfizer, spinoffs
Novartis Ramps Up Alzheimer’s Drug Pursuit as Rivals Fail
Bloomberg
Wednesday, May 22, 2013 - 8:12am
tags:
Novartis, Alzheimer's disease, Roche, Merck, Baxter International
Royalty ups bid as Elan unveils acquisitions
Pharma Times, UK
Tuesday, May 21, 2013 - 12:17pm
tags:
Elan, M&A, Royalty Pharma
Pfizer Has Second Recall of Thyroid-Disorder Drug Levoxyl
NASDAQ.com
Tuesday, May 21, 2013 - 12:17pm
tags:
Pfizer, Levoxyl, recalls
J&J Asks Employees To Assess Its Battered Corporate Credo
Pharmalot
Tuesday, May 21, 2013 - 12:14pm
tags:
JNJ
CytRx announces data from Phase 1b trial of aldoxorubicin
Yahoo/Fly on the Wall
Tuesday, May 21, 2013 - 12:13pm
tags:
CytRx, aldoxorubicin, solid tumors
A Game-Changing Cancer Screen For Exact Sciences
Seeking Alpha
Tuesday, May 21, 2013 - 12:09pm
tags:
EXACT Sciences, cancer
2013 FDA Drug Approval Calendar
TheStreet.com
Tuesday, May 21, 2013 - 12:05pm
tags:
drug approvals, GSK, Dolutegravir, Trametenib, Auxilium, Xiaflex, Delcath, Melblez, Seattle Genetics, Adcetris, Antares, Otrexup, Amag Pharmaceuticals, Feraheme, Cubist Pharmaceuticals, Entereg, Gilead, sofosbuvir, Amarin, Vascepa, Merck, suvorexant, Valeant Pharmaceuticals, efinaconazole, Depomed, Sefelsa, Zogenix, Zohydro, dabrafenib, tivozanib, Aveo Pharmaceuticals
Cubist Pharmaceuticals shares leap late after ruling on patent cases
Marketwatch
Tuesday, May 21, 2013 - 11:49am
tags:
patents, Cubist Pharmaceuticals, Hospira, Cubicin, antibiotics, generics
Vascepa Data Should Make Amarin Longs Worried
Seeking Alpha
Tuesday, May 21, 2013 - 11:47am
tags:
Amarin, Vascepa
A New Drug Sales Model
Motley Fool
Tuesday, May 21, 2013 - 11:47am
tags:
Pfizer, Viagra
France ignores EMA and suspends Bayer acne treatment Diane 35
CP Wire
Tuesday, May 21, 2013 - 11:46am
tags:
France, Bayer, Diane 35, acne
The Facebook Effect On Arena's Belviq Sales And Why It Will Ultimately Dwarf Anything Eisai Does
Seeking Alpha
Tuesday, May 21, 2013 - 11:00am
tags:
Arena Pharmaceuticals, obesity, Belviq, Vivus, Qsymia, Eisai, social media, Facebook
Will Influenza A H7N9 Generate Opportunities For Pharma?
Seeking Alpha
Tuesday, May 21, 2013 - 10:58am
tags:
H7N9, Flu, Gilead, GSK, Novavax, Novartis, Roche, Sanofi
New Asthma Drug Generates Excitement For Patients -- And Its Maker
Forbes
Tuesday, May 21, 2013 - 10:13am
tags:
asthma, Regeneron, dupilumab
AstraZeneca says Phase III studies of Naloxegol met primary, secondary endpoints
The Fly on the Wall
Tuesday, May 21, 2013 - 10:12am
tags:
AstraZeneca, Naloxegol, opioid-induced constipation
Pfizer halts study of lymphoma drug unlikely to help survival
Reuters
Tuesday, May 21, 2013 - 10:08am
tags:
Pfizer, inotuzumab, non-Hodgkin's lymphoma
[video]AbbVie's New Crohn's Disease Drug Candidate
Motley Fool
Tuesday, May 21, 2013 - 10:06am
tags:
AbbVie, Crohn's Disease, JAK inhibitors, Galapagos

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.